Scarica l'app Stockscreener
2.31
59.38%
0.86
Rani Therapeutics Holdings Inc Azioni (RANI) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
100.00%
-
|
0.172 | 1.028 | - | - |
Operating Expenses
|
13.79%
10.51
|
12.19 | 15.99 | 11.80 | 12.52 |
| Interest Income/Expense |
7.00%
0.877
|
0.943 | 1.124 | 1.337 | 1.276 |
| Benefits Costs and Expenses |
13.06%
11.22
|
12.91 | - | - | - |
| Costs And Expenses |
13.06%
11.22
|
12.91 | - | - | - |
| Depreciation and Amortization |
4.38%
0.24
|
0.251 | 0.266 | 0.259 | 0.255 |
| Operating Income/Loss |
12.55%
-10.51
|
-12.01 | -14.96 | -11.80 | -12.52 |
| Income/Loss From Continuing Operations Before Tax |
11.89%
-11.22
|
-12.74 | -15.72 | -12.72 | -13.36 |
| Income/Loss From Continuing Operations After Tax |
11.89%
-11.22
|
-12.74 | -15.72 | -12.72 | -13.36 |
|
Net Income/Loss
|
11.89%
-11.22
|
-12.74 | -15.72 | -12.72 | -13.36 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
17.21%
-4.532
|
-5.474 | -6.775 | -5.939 | -6.556 |
| Basic Average Shares |
9.28%
36.54
|
33.44 | -27.04 | 28.84 | 26.32 |
| Diluted Average Shares |
9.28%
36.54
|
33.44 | -27.04 | 28.84 | 26.32 |
| Basic Earnings Per Share |
18.18%
-0.18
|
-0.22 | -0.27 | -0.24 | -0.26 |
| Diluted Earnings Per Share |
18.18%
-0.18
|
-0.22 | -0.27 | -0.24 | -0.26 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
0.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):